18.03.2020 15:13:17

Stock Alert: IMV Up 32%; Plans To Develop Vaccine Against Covid-19

(RTTNews) - Shares of IMV Inc. (IMV) are currently up 32% after the thinly-traded pharma company announced plans to develop a COVID-19 vaccine based on its lipid-based delivery platform called DPX.

The clinical-stage biopharmaceutical company said it is advancing the clinical development of a DPX-based vaccine candidate against COVID-19.

The company believes that this peptide-based approach, together with the portability of the DPX platform, offers the possibility of accelerated development and rapid, large-scale production of a vaccine.

Nachrichten zu IMV Inc Registered Shsmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu IMV Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!